Login to view
Course Activities.
|
Title: |
Activity/Course #: |
Cost: |
Release/Start Date: |
Expiration Date: |
Topics: |
Target Audience: |
Medium/Method: |
Estimated Time To Complete CME Activity: |
Hardware/Software Requirements: |
Credits: |
|
The program was captured live from the NACE Emerging Challenges in Primary Care: Update 2007 series and features Dr. Julie Harper. Dr. Harper is the Clinical Associate Professor of Dermatology at the University of Alabama-Birmingham. Learning Objective(s): After completing this program participants should be able to:
- recognize common skin problems like Acne and Rosacea andunderstand their pathogenesis
- identify and offer effective, state of the art treatment options
This webcast was recorded live and is being used with the permission of the presenter. |
|
|
National Association for Continuing Education
|
| The National Association for Continuing Education is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The National Association for Continuing Education designates this educational activity for a maximum of 1 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity. |
|
Julie Harper, MD made the following disclosures:
Research grants—Galderma
Consultant—Intendis
Speaker's Bureau—Allergan, Collagenex, and Stiefel
Gregg Sherman, MD, Course Director, has no relationships to disclose.
Harvey Parker, PhD, Activity Planning Committee, has no relationships to disclose.
Michelle Frisch, MPH, Activity Planning Committee, has no relationships to disclose.
Alan Goodstat, LCSW, Activity Planning Committee, has no relationships to disclose. |
|
No commercial support was provided for this enduring activity. The following companies provided commercial support for the live CME activity entitled Emerging Challenges in Primary Care: Update 2007 held in Birmingham, AL on March 31, 2007 during which this presentation was held:Amylin, AstraZeneca, Boehringer Ingelheim, Collagenex, Merck, NovoNordisk, sanofi-aventis, Takeda Pharmaceuticals of North America, Wyeth. |
|